✦ LIBER ✦

Docetaxel in patients with non-small cell lung cancer relapsed or progressed after first-line chemotherapy

✍ Scribed by Teixeira, E; Sotto-Mayor, R; Borges, M; Almodovar, T; Duro da Costa, J; Bugalho de Almeida, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-small-cell lung cancer progression a

✍ Primo N. Lara; Derick H. M. Lau; David R. Gandara 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 212 KB

Second-line chemotherapy in relapsing or

✍ Georgoulias, Vassilis A 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB

First-line chemotherapy rechallenge afte

✍ Mark Vincent; Barrie Evans; Ian Smith 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 345 KB

Neoadjuvant chemotherapy with docetaxel

✍ Karin Mattson 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Survival among non-small cell lung cance

✍ Salloum, Ramzi G.; Smith, Thomas J.; Jensen, Gail A.; Lafata, Jennifer Elston 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB